What’s New in MG Research

Wondering about the most recent progress in myasthenia gravis treatments research and clinical trials?

Join a “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now.

Tuesday, August 26 @ 2:00 PM Eastern Time (US and Canada)

Whether you were just diagnosed or have been living with myasthenia gravis for a long time, daily life can be tough. Things like talking, smiling, or having a simple conversation may feel hard. And as symptoms get worse, it can be even harder to find a treatment that really helps. But now, new treatments are giving people more hope.

Join us for a special live program on Tuesday, August 26, 2025, at 2:00 PM ET with a doctor who treats MG and a person who lives with MG. They will talk about their experiences, how MG affects daily life, and why older treatments do not always work well for everyone. You’ll also hear about new treatments are giving people more hope.

Produced in partnership with the National Organization for Rare Diseases (NORD) and Medlive.

Register Now

Thursday, August 21, 2025 @ 1:00 PM Eastern Time (US and Canada)

Join us to learn about anito-cel, a novel BCMA-targeted DNA CAR T-cell therapy that is being developed by Arcellx for generalized myasthenia gravis (gMG). Dr. Chris Heery, Chief Medical Officer at Arcellx, will explain how CAR T-cell therapy works and introduce the clinical trial of anito-cel in gMG.

Sponsored by Arcellx.

Register Now